Cargando…

S37. CROSS-CULTURAL DIFFERENCES IN PANSS ITEM RATINGS: COMPARISONS OF SIX GEO-CULTURAL REGIONS

BACKGROUND: While schizophrenia is observed in different parts of the world across countries, ethnicities, and races, research indicates cultural factors play significant roles in the phenomenology of this illness. Cultural norms and values affect manifestations of this pathology; more specifically,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Crittenden, Kia, Machizawa, Sayaka, Todd Feaster, H, Barbone, Jordan M, Hong, Bomi, Verma, Prateek, Zhou, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Session I
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7234172/ http://dx.doi.org/10.1093/schbul/sbaa031.103

Ejemplares similares

S244. RELIABILITY OF CORE SCHIZOPHRENIA SYMPTOMS RATINGS USING THE SIX-ITEM POSITIVE AND NEGATIVE SYNDROME SCALE (PANSS-6) PERFORMED BY MEDICAL STUDENTS
por: Hansen, Johanna, et al.
Publicado: (2020)

M35. CLINICAL VALIDATION OF THE SIX-ITEM POSITIVE AND NEGATIVE SYNDROME SCALE (PANSS-6)
por: Kølbæk, Pernille, et al.
Publicado: (2020)

S71. CLINICAL, BEHAVIOURAL AND NEURAL VALIDATION OF THE POSITIVE AND NEGATIVE SYMPTOM SCALE (PANSS) AMOTIVATION FACTOR
por: Kaliuzhna, Mariia, et al.
Publicado: (2020)

A rasch model to test the cross-cultural validity in the positive and negative syndrome scale (PANSS) across six geo-cultural groups
por: Khan, Anzalee, et al.
Publicado: (2013)

M210. GRIN2B METHYLATION IS RELATED TO PANSS EXCITED COMPONENT (PANSS-EC) IN SCHIZOPHRENIA
por: Fachim, Helene, et al.
Publicado: (2020)

Standardized training in the rating of the six-item positive and negative syndrome scale (PANSS-6)
por: Kølbæk, P., et al.
Publicado: (2021)

M40. ECT VERSUS SHAM FOR CLOZAPINE RESISTANT SCHIZOPHRENIA: A SECONDARY ANALYSIS OF A PILOT STUDY BASED ON PANSS-30 FACTOR ANALYTIC DIMENSIONS AND THE PANSS-6
por: Luciana Melzer-Ribeiro, Debora, et al.
Publicado: (2020)

S236. QUALITY OF LIFE AND ASSOCIATION WITH SYMPTOMS IN PATIENTS WITH SCHIZOPHRENIA SIX YEARS AFTER FIRST EPISODE PSYCHOSES
por: Andersen, Gitte, et al.
Publicado: (2020)

M42. INDEPENDENT REVIEW & MONITORING IMPROVES QUALITY OF PANSS DATA IN GLOBAL CLINICAL TRIALS
por: Echevarria, Barbara, et al.
Publicado: (2020)

S26. PSYCHOSIS-SPECTRUM SYMPTOMS AMONG ADOLESCENTS PSYCHIATRICALLY HOSPITALIZED FOR ACUTE SAFETY CONCERNS ARE LINKED TO READMISSION WITHIN SIX MONTHS OF DISCHARGE
por: Thompson, Elizabeth, et al.
Publicado: (2020)

Item Response Theory to Quantify Longitudinal Placebo and Paliperidone Effects on PANSS Scores in Schizophrenia
por: Krekels, EHJ, et al.
Publicado: (2017)

T12. THE RELATIONSHIP OF INTESTINAL PERMEABILITY FACTORS WITH SOCIODEMOGRAPHIC AND PHYSICAL HEALTH FACTORS AND PANSS SCORES IN SCHIZOPHRENIA PATIENTS AND HEALTHY CONTROLS
por: Borkent, Jenny, et al.
Publicado: (2020)

T111. PANSS NEGATIVE SYMPTOM DIMENSIONS ACROSS GEOGRAPHICAL REGIONS: IMPLICATIONS FOR SOCIAL, LINGUISTIC AND CULTURAL CONSISTENCY
por: Khan, Anzalee, et al.
Publicado: (2018)

Antipsychotic-placebo separation on the PANSS-6 subscale as compared to the PANSS-30: a pooled participant-level analysis
por: Hieronymus, Fredrik, et al.
Publicado: (2021)

Use of NON-PARAMETRIC Item Response Theory to develop a shortened version of the Positive and Negative Syndrome Scale (PANSS)
por: Khan, Anzalee, et al.
Publicado: (2011)

Is the PANSS used correctly? a systematic review
por: Obermeier, Michael, et al.
Publicado: (2011)

When I say … cultural competence
por: Stanyon, Maham, et al.
Publicado: (2021)

Patterns of schizophrenia symptoms: hidden structure in the PANSS questionnaire
por: Lefort-Besnard, Jérémy, et al.
Publicado: (2018)

GEO-LIFE COURSE DETERMINANTS OF EDUCATIONAL DISPARITIES IN U.S. ADULT HEALTH
por: Kemp, Blakelee, et al.
Publicado: (2019)

S49. THE RELATION BETWEEN PROCESSING SPEED AND USAGE OF MOBILE APPLICATIONS IN PATIENTS WITH SCHIZOPHRENIA
por: Hoşgelen, Emine Ilgın, et al.
Publicado: (2020)

S29. ONE-CARBON METABOLISM AND STRESS IN CHILDREN AND ADOLESCENTS WITH PSYCHOSIS RISK SYNDROME: PRELIMINARY DATA
por: Baeza, Inmaculada, et al.
Publicado: (2020)

S17. GLOBAL DNA METHYLATION IN CURRENT AND EMERGENT SUICIDAL IDEATION: ANALYSIS IN SCHIZOPHRENIA
por: Bani-Fatemi, Ali, et al.
Publicado: (2020)

S14. ANALYSIS OF METHYLATION AGE AND BLOOD CELL COMPOSITION IN SUBJECTS WITH CURRENT SUICIDE IDEATION
por: Dada, Oluwagbenga, et al.
Publicado: (2020)

S234. DEPRESSION AND SEXUAL FUNCTIONING: TWO NEGLECTED AND PREVALENT DOMAINS IN PEOPLE WITH SCHIZOPHRENIA
por: Lapa, Clara, et al.
Publicado: (2020)

S61. COMPUTATIONAL MODELLING OF VISUAL MOTION PERCEPTION AND ITS ASSOCIATION WITH SCHIZOTYPAL TRAITS
por: Farkas, Kinga, et al.
Publicado: (2020)

S11. PLASMA LEPTIN AND ANTHRANILIC ACID IN SCHIZOPHRENIA PATIENTS: NEW BIOMARKERS OF PREDISPOSITION TO METABOLIC ABNORMALITIES
por: Steiner, Johann, et al.
Publicado: (2020)

S52. SPATIAL MEMORY DEFICITS IN SCHIZOPHRENIA: NEUROLOGICAL SOFT SIGNS DIFFERENTIALLY INFLUENCE PERFORMANCES IN 3-D VIRTUAL VERSUS TACTILE RECOGNITION TASKS
por: Abichou, Kouloud, et al.
Publicado: (2020)

S34. EFFECTIVENESS OF INDIVIDUAL METACOGNITIVE TRAINING (MCT+) IN FIRST-EPISODE PSYCHOSIS
por: Ochoa, Susana, et al.
Publicado: (2020)

S224. TREATMENT IN THE PSYCHOSIS FIRST EPISODE PROGRAM “ZüRCHER ERSTPSYCHOSEN NETZWERK (ZEN)”: QUALITY CONTROL OF THE OUTCOME
por: Metzler, Sibylle, et al.
Publicado: (2020)

S68. DIFFERENTIAL PATTERN OF SOCIAL COGNITION IMPAIRMENT BETWEEN RURAL AND URBAN DWELLING PATIENTS OF SCHIZOPHRENIA AND ITS FUNCTIONAL CORRELATES
por: Ibrahim, Ferose, et al.
Publicado: (2020)

S43. ASSESSING THE VARIABILITY OF RESPONSE TO NON-INVASIVE BRAIN STIMULATION IN PSYCHOSIS
por: Winkelbeiner, Stephanie, et al.
Publicado: (2020)

S67. TREATMENT-RESISTANCE AFFECTS LONG-TERM COGNITIVE TRAJECTORIES IN SCHIZOPHRENIA: A LONGITUDINAL STUDY
por: Spangaro, Marco, et al.
Publicado: (2020)

S22. SPECIFIC PSYCHOTIC EXPERIENCES AND DEPRESSIVE SYMPTOMS IN CHILEAN ADOLESCENTS: A MULTIPLE MEDIATION MODEL OF THEIR IMPACT ON SUICIDAL IDEATION
por: Nunez, Daniel, et al.
Publicado: (2020)

S24. PATHWAYS LINKING ENVIRONMENTAL RISKS, POLYGENIC RISK SCORE TO SCHIZOPHRENIA AND PSYCHOTIC EXPERIENCES IN A BRAZILIAN COHORT OF CHILDREN AND ADOLESCENTS
por: Fonseca, Lais, et al.
Publicado: (2020)

S31. ENHANCEMENT OF SYNAPTIC PLASTICITY BY COMBINATION OF PDE2 AND PDE9 INHIBITION PRESUMABLY VIA PRE- AND POST-SYNAPTIC MECHANISMS
por: Rosenbrock, Holger, et al.
Publicado: (2020)

S64. COGNITIVE IMPAIRMENTS AND PREDICTION OF FUNCTIONAL OUTCOME IN INDIVIDUALS AT CLINICAL HIGH-RISK FOR PSYCHOSIS
por: Haining, Kate, et al.
Publicado: (2020)

S48. INSIGHT VS COGNITION AND SYMPTOMATIC REMISSION AMONG PATIENTS WITH SCHIZOPHRENIA- THE INFLUENCE OF TRAIT VS STATE PHENOMENON?
por: Helldin, Lars, et al.
Publicado: (2020)

S35. THE PLACEBO CONUNDRUM: MITIGATING THE RESPONSE AT THE SITE LEVEL
por: Hassman, Howard, et al.
Publicado: (2020)

S10. SCREENING FOR ANTI-NMDAR ANTIBODIES AMONGST PATIENTS WITH FIRST EPISODE PSYCHOSIS
por: Herman, Levente, et al.
Publicado: (2020)

S56. SWITCHING FROM RISPERIDONE TO PALIPERIDONE PALMITATE IN SCHIZOPHRENIA: CHANGES IN COGNITIVE FUNCTION
por: Tost Bonet, Meritxell, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_r32ntnpqep5mmpa9kg40q8krd2